Details of Disease | DrugMAP

General Information of Disease (ID: DIS4TDCK)

Disease Name	Rubella prophylaxis
Disease Class	1F02: Rubella
Disease Hierarchy	DIS01GPL: Grass pollen hypersensitivity DIS4TDCK: Rubella prophylaxis
ICD Code	ICD-11 ICD-11: 1F02 ICD-10 ICD-10: B06

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 3 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
MMR	DMYW8UN	Phase 3	NA	[1]
MMR vaccine	DMELN09	Phase 3	NA	[2]
SB209762	DM7Y368	Phase 3	Vaccine	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	ClinicalTrials.gov (NCT02184572) Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine inHealthy Children 12 to 15 Months of Age. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	Clinical pipeline report, company report or official report of GlaxoSmithKline.